Akebia Therapeutics (AKBA) Amortization - Intangibles (2019 - 2024)

Akebia Therapeutics (AKBA) has 6 years of Amortization - Intangibles data on file, last reported at $9.0 million in Q4 2024.

• Amortization - Intangibles for Q4 2024 came in at $9.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $9.0 million (down 75.0% YoY), and the FY2024 annual result was $36.0 million, changed 0.0% from the prior year.
• Amortization - Intangibles was little changed at $9.0 million in Q4 2024 per AKBA's latest filing, from $9.0 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $9.1 million in Q2 2020 and troughed at $6.1 million in Q3 2020.
• A 5-year average of $8.8 million and a median of $9.0 million in 2021 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2020 and 2021: Amortization - Intangibles plunged 32.91% in 2020, then jumped 47.58% in 2021.
• A 5-year view of Amortization - Intangibles shows it stood at $8.3 million in 2020, then gained by 8.42% to $9.0 million in 2021, then changed by 0.0% to $9.0 million in 2022, then changed by 0.0% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024.
• Business Quant data shows AKBA's Amortization - Intangibles at $9.0 million in Q4 2024, $9.0 million in Q3 2024, and $9.0 million in Q2 2024.